PMV Pharmaceuticals Inc.

NASDAQ: PMVP · Real-Time Price · USD
1.50
-0.05 (-3.23%)
At close: Aug 15, 2025, 3:59 PM
1.52
1.00%
After-hours: Aug 15, 2025, 04:04 PM EDT

PMV Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
1.14M 1.26M 650K 1.28M
Gross Profit
n/a -1.26M -650K -1.28M
Operating Income
-85.45M -80.13M -77.04M -58.29M
Interest Income
n/a 11.17M 3.63M 449K
Pretax Income
-74.81M -68.96M -73.33M -57.82M
Net Income
-58.71M -68.96M -73.32M -57.85M
Selling & General & Admin
26.92M 24.25M 25.05M 21.8M
Research & Development
58.53M 54.63M 51.99M 36.49M
Other Expenses
n/a n/a 87K 21K
Operating Expenses
85.45M 80.13M 77.04M 58.29M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
n/a 80.13M 77.04M 58.29M
Income Tax Expense
-16.1M 2K -9K 23K
Shares Outstanding (Basic)
51.58M 48.01M 45.59M 45.14M
Shares Outstanding (Diluted)
51.58M 48.01M 45.59M 45.14M
EPS (Basic)
-1.14 -1.44 -1.61 -1.28
EPS (Diluted)
-1.14 -1.44 -1.61 -1.28
EBITDA
-73.67M -78.88M -76.72M -57.99M
EBIT
-74.81M -80.13M -77.04M -58.29M
Depreciation & Amortization
1.14M 1.26M 650K 1.28M